Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PER WORM ISOLERING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.5%   Bankruptcy risk   10.1% 3.1% 2.1% 1.4% 2.5% 6.4% 14.9% 11.8%   Credit score (0-100)   26 58 68 78 61 36 13 20   Credit rating   BB BBB BBB A BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.1 10.6 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,293 1,221 1,620 1,775 1,588 1,453 0.0 0.0   EBITDA   -574 226 577 350 67.5 -277 0.0 0.0   EBIT   -617 190 550 316 32.8 -309 0.0 0.0   Pre-tax profit (PTP)   -629.6 150.2 540.8 307.7 27.1 -349.8 0.0 0.0   Net earnings   -683.6 150.2 503.9 236.1 19.8 -282.6 0.0 0.0   Pre-tax profit without non-rec. items   -630 150 541 308 27.1 -350 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Tangible assets total   957 989 962 952 917 886 0.0 0.0   Shareholders equity total   270 421 871 1,051 1,015 675 550 550   Interest-bearing liabilities   327 296 265 233 202 172 0.0 0.0   Balance sheet total (assets)   1,278 1,527 1,654 2,006 1,812 1,595 550 550   Net Debt   266 83.8 -73.9 -57.2 180 -140 -550 -550     See the entire balance sheet 1000.0 Volume  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,293 1,221 1,620 1,775 1,588 1,453 0.0 0.0   Gross profit growth   -23.0% -5.6% 32.6% 9.6% -10.6% -8.5% -100.0% 0.0%   Employees   4 3 3 4 3 3 0 0   Employee growth %   33.3% -25.0% 0.0% 33.3% -25.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,278 1,527 1,654 2,006 1,812 1,595 550 550   Balance sheet change%   -29.7% 19.5% 8.3% 21.3% -9.7% -12.0% -65.5% 0.0%   Added value   -573.9 225.8 577.3 349.9 66.2 -277.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -85 -4 -54 -44 -69 -63 -886 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 4.0 -1.0 0.0 0.0   1000.0 Profitability  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -47.7% 15.5% 34.0% 17.8% 2.1% -21.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -39.8% 13.5% 34.6% 17.3% 1.7% -18.1% 0.0% 0.0%   ROI %   -64.6% 28.9% 58.2% 24.7% 2.4% -27.7% 0.0% 0.0%   ROE %   -111.7% 43.5% 78.1% 24.6% 1.9% -33.5% 0.0% 0.0%   1000.0 Solidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Equity ratio %   21.2% 27.5% 52.6% 52.4% 56.0% 42.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -46.3% 37.1% -12.8% -16.3% 266.6% 50.5% 0.0% 0.0%   Gearing %   121.1% 70.5% 30.4% 22.2% 19.9% 25.5% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.8% 12.7% 3.4% 3.5% 2.6% 22.0% 0.0% 0.0%   1000.0 Liquidity  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Quick Ratio   0.4 0.6 1.3 1.6 1.4 0.8 0.0 0.0   Current Ratio   0.5 0.6 1.3 1.6 1.7 1.0 0.0 0.0   Cash and cash equivalent   61.6 212.6 338.9 290.6 22.0 312.2 0.0 0.0   1000.0 Capital use efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -385.6 -303.3 178.7 408.9 382.7 -20.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2018/6 2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -143 75 192 87 22 -92 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -143 75 192 87 22 -92 0 0   EBIT / employee   -154 63 183 79 11 -103 0 0   Net earnings / employee   -171 50 168 59 7 -94 0 0